Sara Apter

Tel Aviv University — Israel

Medicine · Health Sciences

35h-index5.0kcitations177works2.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(21), Immunotherapy and Immune Responses(20), CAR-T cell therapy research(20), Cardiac Imaging and Diagnostics(17), Pancreatic and Hepatic Oncology Research(12)

Publications177 total

Exploring pancreatic variability in BRCA carriers vs. Non-Carriers: A diffusion tensor MRI study
European Journal of Radiology·2025Open Access
Renal Fat Accumulation Assessed by MRI or CT and Its Association with Clinical and Metabolic Disorders: A Systematic Imaging Review
Journal of Clinical Medicine·2025· 3 citedOpen Access
860 MRguided prostate SBRT for prostate cancer. A single centre series of 440 consecutive patients.
Radiotherapy and Oncology·2025
Obesity Is Associated with Fatty Liver and Fat Changes in the Kidneys in Humans as Assessed by MRI
Nutrients·2024· 8 citedOpen Access
Comparison of the deep learning tool iDAScore® and the current annotation model, KIDScore™ D5, for finding the embryo with best chance of pregnancy after elective single blastocyst transfer – a randomized multi-centre prospective pilot study
Reproductive BioMedicine Online·2024
Pancreatic cancer outcome—local treatment with radiation using MRI-LINAC
Frontiers in Oncology·2023Open Access
Undetected Pancreatic Adenocarcinoma on Computed Tomography: Frequency According to Scan Protocol.
PubMed·2023
MRI features of intraductal papillary mucinous neoplasm of the bile ducts, “The myth about the cyst”: A systematic review
European Journal of Radiology Open·2023· 4 citedOpen Access
Perivascular Cuffing as the Sole Imaging Finding of Pancreatic Cancer.
PubMed·2023
Diffusion-weighted MRI for predicting and assessing treatment response of liver metastases from CRC – A systematic review and meta-analysis
European Journal of Radiology·2023· 18 cited
Data from Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study
2023Open Access
Sup. Table 2 from Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study
2023Open Access
Sup. Table 1 from Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study
2023Open Access
Data from Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study
2023Open Access
Sup. Table 2 from Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study
2023Open Access
Sup. Table 1 from Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study
2023Open Access
CCR Translation for This Article from Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
2023Open Access
Supplementary Figure 1 from Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
2023Open Access
Supplementary Table 3 from Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
2023Open Access
Data from Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Gabriela Gayer(15), Rivka Zissin(14), M. Hertz(11), Y Itzchak(11), Joseph Shemesh(10), Michael Motro(9), Arnon Nagler(6), Judith Rozenman(6), Ehud Grossman(6), Avichai Shimoni(5), Michal Amitai(5), Orith Portnoy(5), Marjorie Hertz(5), Ronnie Shapira‐Frommer(4), Gal Markel(4), Jacob Schachter(4), Michal J. Besser(3), Avraham J. Treves(3), Orit Itzhaki(3), Adva Kubi(3)